KIM, In Soo; JO, Eun-Kyoung. Inosine: A bioactive metabolite with multimodal actions in human diseases. Frontiers in Pharmacology. 2022, roč. 13, s. 1043970. PMID: 36467085
PMCID: PMC9708727. Dostupné online [cit. 2025-06-16]. ISSN1663-9812. doi:10.3389/fphar.2022.1043970. PMID36467085.
HASKÓ, György; SITKOVSKY, Michail V.; SZABÓ, Csaba. Immunomodulatory and neuroprotective effects of inosine. Trends in Pharmacological Sciences. 2004-03-01, roč. 25, čís. 3, s. 152–157. PMID: 15019271. Dostupné online [cit. 2025-06-16]. ISSN0165-6147. doi:10.1016/j.tips.2004.01.006. PMID15019271. (English)
MAGER, Lukas F.; BURKHARD, Regula; PETT, Nicola. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science (New York, N.Y.). 2020-09-18, roč. 369, čís. 6510, s. 1481–1489. PMID: 32792462. Dostupné online [cit. 2025-06-16]. ISSN1095-9203. doi:10.1126/science.abc3421. PMID32792462.
HASKÓ, György; SITKOVSKY, Michail V.; SZABÓ, Csaba. Immunomodulatory and neuroprotective effects of inosine. Trends in Pharmacological Sciences. 2004-03, roč. 25, čís. 3, s. 152–157. Dostupné online [cit. 2025-06-16]. ISSN0165-6147. doi:10.1016/j.tips.2004.01.006.
BERAN, Jiří; ŠPAJDEL, Marián; SLÍVA, Jiří. Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course. Viruses. 2021-11-09, roč. 13, čís. 11, s. 2246. PMID: 34835052
PMCID: PMC8619495. Dostupné online [cit. 2025-06-16]. ISSN1999-4915. doi:10.3390/v13112246. PMID34835052.
WANG, Tingting; GNANAPRAKASAM, J. N. Rashida; CHEN, Xuyong. Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction. Nature Metabolism. 2020-07, roč. 2, čís. 7, s. 635–647. PMID: 32694789
PMCID: PMC7371628. Dostupné online [cit. 2025-06-16]. ISSN2522-5812. doi:10.1038/s42255-020-0219-4. PMID32694789.
MAO, Bingyong; GUO, Weiling; TANG, Xin. Inosine Pretreatment Attenuates LPS-Induced Lung Injury through Regulating the TLR4/MyD88/NF-κB Signaling Pathway In Vivo. Nutrients. 2022-07-09, roč. 14, čís. 14, s. 2830. PMID: 35889786
PMCID: PMC9318366. Dostupné online [cit. 2025-06-16]. ISSN2072-6643. doi:10.3390/nu14142830. PMID35889786.
LIAUDET, Lucas; MABLEY, Jon G.; PACHER, Pál. Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury. Annals of Surgery. 2002-04, roč. 235, čís. 4, s. 568–578. PMID: 11923614
PMCID: PMC1422473. Dostupné online [cit. 2025-06-16]. ISSN0003-4932. doi:10.1097/00000658-200204000-00016. PMID11923614.
LOMTE, Tarun Sai. Microbes in your gut could determine cancer treatment outcomes. News-Medical [online]. 2025-02-04 [cit. 2025-06-16]. Dostupné online. (anglicky)
KIM, In Soo; JO, Eun-Kyoung. Inosine: A bioactive metabolite with multimodal actions in human diseases. Frontiers in Pharmacology. 2022, roč. 13, s. 1043970. PMID: 36467085
PMCID: PMC9708727. Dostupné online [cit. 2025-06-16]. ISSN1663-9812. doi:10.3389/fphar.2022.1043970. PMID36467085.
HASKÓ, György; SITKOVSKY, Michail V.; SZABÓ, Csaba. Immunomodulatory and neuroprotective effects of inosine. Trends in Pharmacological Sciences. 2004-03-01, roč. 25, čís. 3, s. 152–157. PMID: 15019271. Dostupné online [cit. 2025-06-16]. ISSN0165-6147. doi:10.1016/j.tips.2004.01.006. PMID15019271. (English)
MAGER, Lukas F.; BURKHARD, Regula; PETT, Nicola. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science (New York, N.Y.). 2020-09-18, roč. 369, čís. 6510, s. 1481–1489. PMID: 32792462. Dostupné online [cit. 2025-06-16]. ISSN1095-9203. doi:10.1126/science.abc3421. PMID32792462.
BERAN, Jiří; ŠPAJDEL, Marián; SLÍVA, Jiří. Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course. Viruses. 2021-11-09, roč. 13, čís. 11, s. 2246. PMID: 34835052
PMCID: PMC8619495. Dostupné online [cit. 2025-06-16]. ISSN1999-4915. doi:10.3390/v13112246. PMID34835052.
WANG, Tingting; GNANAPRAKASAM, J. N. Rashida; CHEN, Xuyong. Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction. Nature Metabolism. 2020-07, roč. 2, čís. 7, s. 635–647. PMID: 32694789
PMCID: PMC7371628. Dostupné online [cit. 2025-06-16]. ISSN2522-5812. doi:10.1038/s42255-020-0219-4. PMID32694789.
MAO, Bingyong; GUO, Weiling; TANG, Xin. Inosine Pretreatment Attenuates LPS-Induced Lung Injury through Regulating the TLR4/MyD88/NF-κB Signaling Pathway In Vivo. Nutrients. 2022-07-09, roč. 14, čís. 14, s. 2830. PMID: 35889786
PMCID: PMC9318366. Dostupné online [cit. 2025-06-16]. ISSN2072-6643. doi:10.3390/nu14142830. PMID35889786.
LIAUDET, Lucas; MABLEY, Jon G.; PACHER, Pál. Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury. Annals of Surgery. 2002-04, roč. 235, čís. 4, s. 568–578. PMID: 11923614
PMCID: PMC1422473. Dostupné online [cit. 2025-06-16]. ISSN0003-4932. doi:10.1097/00000658-200204000-00016. PMID11923614.
KIM, In Soo; JO, Eun-Kyoung. Inosine: A bioactive metabolite with multimodal actions in human diseases. Frontiers in Pharmacology. 2022, roč. 13, s. 1043970. PMID: 36467085
PMCID: PMC9708727. Dostupné online [cit. 2025-06-16]. ISSN1663-9812. doi:10.3389/fphar.2022.1043970. PMID36467085.
BERAN, Jiří; ŠPAJDEL, Marián; SLÍVA, Jiří. Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course. Viruses. 2021-11-09, roč. 13, čís. 11, s. 2246. PMID: 34835052
PMCID: PMC8619495. Dostupné online [cit. 2025-06-16]. ISSN1999-4915. doi:10.3390/v13112246. PMID34835052.
LIAUDET, Lucas; MABLEY, Jon G.; PACHER, Pál. Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury. Annals of Surgery. 2002-04, roč. 235, čís. 4, s. 568–578. PMID: 11923614
PMCID: PMC1422473. Dostupné online [cit. 2025-06-16]. ISSN0003-4932. doi:10.1097/00000658-200204000-00016. PMID11923614.
pubmed.ncbi.nlm.nih.gov
MAGER, Lukas F.; BURKHARD, Regula; PETT, Nicola. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science (New York, N.Y.). 2020-09-18, roč. 369, čís. 6510, s. 1481–1489. PMID: 32792462. Dostupné online [cit. 2025-06-16]. ISSN1095-9203. doi:10.1126/science.abc3421. PMID32792462.
WANG, Tingting; GNANAPRAKASAM, J. N. Rashida; CHEN, Xuyong. Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction. Nature Metabolism. 2020-07, roč. 2, čís. 7, s. 635–647. PMID: 32694789
PMCID: PMC7371628. Dostupné online [cit. 2025-06-16]. ISSN2522-5812. doi:10.1038/s42255-020-0219-4. PMID32694789.
MAO, Bingyong; GUO, Weiling; TANG, Xin. Inosine Pretreatment Attenuates LPS-Induced Lung Injury through Regulating the TLR4/MyD88/NF-κB Signaling Pathway In Vivo. Nutrients. 2022-07-09, roč. 14, čís. 14, s. 2830. PMID: 35889786
PMCID: PMC9318366. Dostupné online [cit. 2025-06-16]. ISSN2072-6643. doi:10.3390/nu14142830. PMID35889786.
Reactome | PNP catalyzes the conversion of (deoxy)inosine to hypoxanthine and (deoxy)ribose. reactome.org [online]. [cit. 2025-06-16]. Dostupné online.
KIM, In Soo; JO, Eun-Kyoung. Inosine: A bioactive metabolite with multimodal actions in human diseases. Frontiers in Pharmacology. 2022, roč. 13, s. 1043970. PMID: 36467085
PMCID: PMC9708727. Dostupné online [cit. 2025-06-16]. ISSN1663-9812. doi:10.3389/fphar.2022.1043970. PMID36467085.
HASKÓ, György; SITKOVSKY, Michail V.; SZABÓ, Csaba. Immunomodulatory and neuroprotective effects of inosine. Trends in Pharmacological Sciences. 2004-03-01, roč. 25, čís. 3, s. 152–157. PMID: 15019271. Dostupné online [cit. 2025-06-16]. ISSN0165-6147. doi:10.1016/j.tips.2004.01.006. PMID15019271. (English)
MAGER, Lukas F.; BURKHARD, Regula; PETT, Nicola. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science (New York, N.Y.). 2020-09-18, roč. 369, čís. 6510, s. 1481–1489. PMID: 32792462. Dostupné online [cit. 2025-06-16]. ISSN1095-9203. doi:10.1126/science.abc3421. PMID32792462.
HASKÓ, György; SITKOVSKY, Michail V.; SZABÓ, Csaba. Immunomodulatory and neuroprotective effects of inosine. Trends in Pharmacological Sciences. 2004-03, roč. 25, čís. 3, s. 152–157. Dostupné online [cit. 2025-06-16]. ISSN0165-6147. doi:10.1016/j.tips.2004.01.006.
BERAN, Jiří; ŠPAJDEL, Marián; SLÍVA, Jiří. Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course. Viruses. 2021-11-09, roč. 13, čís. 11, s. 2246. PMID: 34835052
PMCID: PMC8619495. Dostupné online [cit. 2025-06-16]. ISSN1999-4915. doi:10.3390/v13112246. PMID34835052.
WANG, Tingting; GNANAPRAKASAM, J. N. Rashida; CHEN, Xuyong. Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction. Nature Metabolism. 2020-07, roč. 2, čís. 7, s. 635–647. PMID: 32694789
PMCID: PMC7371628. Dostupné online [cit. 2025-06-16]. ISSN2522-5812. doi:10.1038/s42255-020-0219-4. PMID32694789.
MAO, Bingyong; GUO, Weiling; TANG, Xin. Inosine Pretreatment Attenuates LPS-Induced Lung Injury through Regulating the TLR4/MyD88/NF-κB Signaling Pathway In Vivo. Nutrients. 2022-07-09, roč. 14, čís. 14, s. 2830. PMID: 35889786
PMCID: PMC9318366. Dostupné online [cit. 2025-06-16]. ISSN2072-6643. doi:10.3390/nu14142830. PMID35889786.
LIAUDET, Lucas; MABLEY, Jon G.; PACHER, Pál. Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury. Annals of Surgery. 2002-04, roč. 235, čís. 4, s. 568–578. PMID: 11923614
PMCID: PMC1422473. Dostupné online [cit. 2025-06-16]. ISSN0003-4932. doi:10.1097/00000658-200204000-00016. PMID11923614.